Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 Agonists by Thomson, Christopher G., Boss, Kelly, Calhoun, Amy, Fridrich, Cary, Gardinier, Kevin M., Hall, Edward C., Jendza, Keith, Kirman, Louise, Labbé-Giguere, Nancy, Laumen, Kurt, Qian, Ming, Sanyal, Sanjit, Shultz, Michael D., Snajdrova, Radka, Tan, Kian, Wang, Kate Yaping, Yang, Fan, Gao, Feng, Hong, Tao, Dale, Elena, Kuzmiski, Brent, Ortuno, Danny, Palacios, Daniel S.

Get full text

The use of MPA amide for the assignment of absolute configuration of a sterically hindered cyclic secondary amine by 'mix and shake' NMR method by Gao, Jinhai, Haas, Hansjoerg, Wang, Kate Yaping, Chen, Zhuoliang, Breitenstein, Werner, Rajan, Srinivasan

Get full text

Throwing light on dark diversity of vascular plants in China: predicting the distribution of dark and threatened species under global climate change by Tang, Lili, Wang, Runxi, He, Kate S, Shi, Cong, Yang, Tong, Huang, Yaping, Zheng, Pufan, Shi, Fuchen

Get full text

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma by Gordon, Leo I, Kaplan, Jason B, Popat, Rakesh, Burris, 3rd, Howard A, Ferrari, Silvia, Madan, Sumit, Patel, Manish R, Gritti, Giuseppe, El-Sharkawi, Dima, Chau, Ian, Radford, John A, Pérez de Oteyza, Jaime, Zinzani, Pier Luigi, Iyer, Swaminathan, Townsend, William, Karmali, Reem, Miao, Harry, Proscurshim, Igor, Wang, Shining, Wu, Yujun, Stumpo, Kate, Shou, Yaping, Carpio, Cecilia, Bosch, Francesc

Get full text

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659... by Gordon, Leo I, Karmali, Reem, Kaplan, Jason B, Popat, Rakesh, Burris, 3rd, Howard A, Ferrari, Silvia, Madan, Sumit, Patel, Manish R, Gritti, Giuseppe, El-Sharkawi, Dima, Chau, F Ian, Radford, John, de Oteyza, Jaime Pérez, Zinzani, Pier Luigi, Iyer, Swaminathan P, Townsend, William, Miao, Harry, Proscurshim, Igor, Wang, Shining, Katyayan, Shilpi, Yuan, Ying, Zhu, Jiaxi, Stumpo, Kate, Shou, Yaping, Carpio, Cecilia, Bosch, Francesc

Get full text

A Phase (ph) 1b/2 Study of TAK-659, an Investigational Dual FLT-3 and SYK Inhibitor, in Patients (Pts) with Relapsed or Refractory Acute Myelogenous Leukemia (R/R AML) by Pratz, Keith, Levis, Mark J., Morris, John C, Wise-Draper, Trisha, Levy, Moshe, Bixby, Dale L., Burke, Patrick, Hernandez, Daniela, Stumpo, Kate, Kannan, Karuppiah, Sheldon-Waniga, Emily, Wang, Shining, Zhang, Steven, Shou, Yaping, Altman, Jessica K., Kaplan, Jason, Frankfurt, Olga

Get full text

Phase 1 Study of TAK-659, an Investigational Reversible Dual SYK/FLT-3 Inhibitor, in Patients (Pts) with Lymphoma: Updated Results from Dose-Escalation and Expansion Cohorts by Kaplan, Jason, Gordon, Leo I., Rambaldi, Alessandro, Gritti, Giuseppe, Popat, Rakesh, Burris, Howard A., Patel, Manish R, Madan, Sumit, Chau, Ian, Radford, John A., Iyer, Swami P., Perez De Oteyza, Jaime, Zinzani, Pier Luigi, Wang, Shining, Sheldon-Waniga, Emily, Stumpo, Kate, Shou, Yaping, Carpio, Cecilia, Bosch, Francesc

Get full text